| Blood eosinophil depletion with mepolizumab, benralizumab, and prednisolone in eosinophilic asthma AM Moran, S Ramakrishnan, CA Borg, CM Connolly, S Couillard, ... American Journal of Respiratory and Critical Care Medicine 202 (9), 1314-1316, 2020 | 45 | 2020 |
| Anti-IL-4/IL-13 for the treatment of asthma: The story so far A Moran, ID Pavord Expert Opinion on Biological Therapy 20 (3), 283-294, 2020 | 35 | 2020 |
| Is higher population‐level use of ICS/LABA combination associated with better asthma outcomes? C ross‐sectional surveys of nationally representative populations in N ew Z … HK Reddel, L Beckert, A Moran, T Ingham, RD Ampon, MJ Peters, ... Respirology 22 (8), 1570-1578, 2017 | 21 | 2017 |
| Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing S Couillard, R Shrimanker, S Lemaire-Paquette, GM Hynes, C Borg, ... Thorax 77 (9), 933-938, 2022 | 8 | 2022 |
| P13 Exhaled nitric oxide and blood eosinophil count in predicting sputum inflammatory type in a heterogeneous airways disease population L Lehtimäki, R Shrimanker, A Moran, G Hynes, S Thulborn, C Borg, ... Thorax 74 (Suppl 2), A95, 2019 | 5 | 2019 |
| COPD exacerbation phenotypes: the next frontier A Moran, I Pavord Respirology 25 (3), 2019 | 4 | 2019 |
| SELF-IDENTIFIED WELL CONTROLLED ASTHMA AND SUB-OPTIMAL ASTHMA CONTROL TEST A Moran, L Beckert Respirology 19, 83-83, 2014 | 2 | 2014 |
| Asthma management in the Asia-Pacific region. L Beckert, A Moran Respirology 19 (1), 2014 | 2 | 2014 |
| Raised FeNO in optimally-treated severe asthma identifies persistent eosinophilic chemotactic pull towards the airway S Couillard, R Shrimanker, G Hynes, C Borg, C Connolly, A Hayman, ... European Respiratory Journal 58 (suppl 65), 2021 | | 2021 |
| Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β2-Adrenoceptors in Acute Asthma AM Moran, S Ramakrishnan, CA Borg, CM Connolly, S Couillard, ... American Journal of Respiratory and Critical Care Medicine 202 (12), 1743-1744, 2020 | | 2020 |
| Mechanisms of FeNO Non-Suppression in Severe Asthma: Analysis of Sputum Type 2 Cytokines and Chemokines S Couillard, R Shrimanker, G Hynes, C Borg, C Connolly, A Hayman, ... European Respiratory Journal 56 (suppl 64), 2020 | | 2020 |
| S128 CyTOF and in vitro analysis of the role of IL-17A in asthma GM Hynes, TL Downs, ST Thulborn, C Connolly, C Borg, A Gittins, ... Thorax 74 (Suppl 2), A81-A82, 2019 | | 2019 |
| S136 Relationship between inflammatory type of obstructive airways disease and lung function in a cohort of the oxford special airways clinic A Moran, G Hynes, L Lehtimaki, R Shrimanker, S Thulborn, C Borg, ... Thorax 74 (Suppl 2), A87-A88, 2019 | | 2019 |
| Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations? A Moran, S Poole, M Harding, M Bafadhel European Respiratory Journal 54 (suppl 63), 2019 | | 2019 |
| INEQUALITIES IN ASTHMA CONTROL FOR MAORI ADULTS IN NEW ZEALAND T Ingham, L Beckert, A Moran, S Sawyer, M Peters, R Ampron, H Reddel RESPIROLOGY 21, 72-72, 2016 | | 2016 |
| SIMILAR CONTROL OF ASTHMA WITH LESS USAGE OF COMBINATION PRODUCTS: A COMPARISON OF SURVEY RESPONSES IN NEW ZEALAND AND AUSTRALIA A Moran, L Beckert, T Ingham, S Sawyer, R Ampon, H Reddel, M Peters RESPIROLOGY 21, 101-101, 2016 | | 2016 |
| WHO DECIDES WHOSE ASTHMA IS CONTROLLED-IS GINA TOO STRICT? A Moran, L Beckert RESPIROLOGY 19, 83-83, 2014 | | 2014 |
| Clinical Care/Education/Nutrition-Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis--Related diabetes A Moran, J Phillips, C Milla Diabetes Care 24 (10), 1706-1710, 2001 | | 2001 |
| Epidemiology/Health Services/Psychosocial S Nag, V Connolly, H King, CE Milla, J Billings, A Moran, RA McGinnis, ... | | |
